She was  initially admitted for scheduled high-dose methotrexate and rituximab dosing and transferred to the ICU with acute mental status decline.
It was due to cerebral edema and encephalopathy developed 2 days after high-dose methotrexate.
Head CT showed midline shift with subfalcine and uncal herniation in the setting of tumor progression.
She was started on high-dose steroids and rituximab with some improvement in mental status.
She received dexamethasone (increased from 6 mg IV q6h to 10 mg IV q6h), mannitol and emergent external beam whole brain cranial irradiation.
S/p 4 induction cycles of high-dose methotrexate initiated on [**2197-6-5**].
Also receiving rituximab since cycle 3 when she did not appear to be responding to methotrexate alone.
- Prior gram positive bacteremia - Hypertension - Hyperlipidemia - s/p oophorectomy  Social History: She lives with husband.
Patient was continued on pulse dose steroids and mannitol, and Keppra for seizure prophylaxis.
Whole brain external beam radiation was started given midline shift.
The patient continued her regimen of radiation, completing radiation therapy on [**2197-7-27**].
The steroids taper was begun and patient was discharged on dexamethasone 4 mg daily, to be tapered further by neuro-oncologist with a follow-up visit in 2 weeks.
Surgery consult recomendeded a conservative approach with antibiotics of antibioticsmonitoring the patient's good clinical status, normal hemodynamics, and absence of leukocytosis.
Pain medications were held and given only after a thorough clinical examination for peritoneal signs.
The patient was treated with a soaps enema, subsequent to which her lactate trended down.
CNS Lymphoma: s/p 3 cycles of high-dose methotrexate combined with rituximab and receiving cranial irradiation c/b acute encephalopathy.
Patient was continued on sodium bicarbonate per methotrexate protocol, and completed course of radiation.
Hypertension: Patient's systolic blood pressure reached a peak of 190-200, secondary to increased intracranial pressure, and recovered with mannitol infusion to SBP 150s on transfer.
Initially the metoprolol was held as it would mask the monitoring of ICP elevation.
After manitol was discontinued, metoprolol was reinitiated with adequate control.
Right Upper Extremity Deep Vein Thrombosis: PICC-associated clot extending to subclavian was noted on prior admission [**2197-6-18**], with PICC discontinued; patient was continued on anticoagulation with enoxoparin.
Patient was discharged on Heparin S.C. 5,000u TID.
She was started on haloperidol for psychosis and agitation.
She will need to continue haloperidol 0.5 mg PO BID standing, together with Celexa.
Medications on Admission: Home Medications: - Enoxaparin 90 mg SC Q12H - Dexamethasone 6 mg IV Q6H - Levetiracetam 1000 mg IV BID - Trimethoprim-Sulfamethoxazole 80-400 mg/5 mL Intravenous Q24H - Pantoprazole 40 mg Daily - Metoprolol Tartrate 2.5 mg IV Twice daily - Lactulose 30 ML 3 times a day - Senna 8.6 mg Daily as needed - Docusate Sodium 100 mg 2 times a day - Multivitamin 1 tab po daily  Discharge Medications: 1.
Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal [**Hospital1 **] (2 times a day) as needed.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO Q8H (every 8 hours) as needed.
Piperacillin-Tazobactam 4.5 gram Recon Soln Sig: One (1) Intravenous every eight (8) hours for 2 days: To complete 14-day course with last day on [**2197-7-29**].
Nystatin 100,000 unit/mL Suspension Sig: Five (5) ML PO QID (4 times a day) as needed for thrush.
Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Trazodone 50 mg Tablet Sig: 0.25 Tablet PO HS (at bedtime) as needed for insomnia.
Haloperidol 0.5 mg Tablet Sig: One (1) Tablet PO TID (3 times a day) as needed for agitation.
Citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Pantoprazole 40 mg Recon Soln Sig: One (1) Recon Soln Intravenous Q24H (every 24 hours).
Haloperidol 0.5 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Morphine Sulfate 2-4 mg IV Q4H:PRN 16.
Lorazepam 0.5-1 mg IV Q4H:PRN 17.
Haloperidol 0.5 mg IV BID:PRN if unable to take PO 18.
Dexamethasone 4 mg IV DAILY 19.
Heparin (Porcine) 5,000 unit/mL Solution Sig: 5000 (5000) units Injection TID (3 times a day).
Discharge Disposition: Extended Care  Facility: [**Location (un) **] Manor - [**Location (un) **]  Discharge Diagnosis: CNS Lymphoma Encephalopathy Bowel ischemia  Discharge Condition: Stable  Discharge Instructions: You were admited for a planned chemotherapy for your lymphoma.
During your hospitalization you were found to have increasing somlonence from swelling in your brain and required transfer to the intensive care unit, as well as medication to help decreased the swelling in your brain.
You tolerated this treatment well and you were transfered back to the floor.
We were able to complete the scheduled chemotherapy and also radiation treatment.
